Clinical Trial Update: Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib [Phase 2]

View source ↗

Summary

Phase 2 biomarker study investigating metastatic clear cell renal cell carcinoma patients treated sequentially with first-line sunitinib and second-line axitini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)
• Sunitinib (sunitinib)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Clear Cell Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN